Endoscopy 2016; 48(02): 149-155
DOI: 10.1055/s-0034-1393244
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Management of the complications of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors

Tao Chen*
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
,
Chen Zhang*
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
,
Li-Qing Yao
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
,
Ping-Hong Zhou
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
,
Yun-Shi Zhong
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
,
Yi-Qun Zhang
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
,
Wei-Feng Chen
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
,
Quan-Lin Li
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
,
Ming-Yan Cai
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
,
Yuan Chu
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
,
Mei-Dong Xu
Endoscopy Center, Zhongshan Hospital, Fudan University, Shanghai, China
› Institutsangaben
Weitere Informationen

Publikationsverlauf

submitted 13. Dezember 2014

accepted after revision 23. Juli 2015

Publikationsdatum:
30. Oktober 2015 (online)

Background and study aims: Submucosal tunneling endoscopic resection (STER) has become a potential option for the endoscopic treatment of a selected group of patients with submucosal tumors (SMTs) originating from the muscularis propria layer in the upper gastrointestinal tract. The aim of this retrospective study was to analyze the incidence and management of STER-related complications.

Patients and methods: From January 2011 to August 2013, 290 patients with upper gastrointestinal SMTs treated by STER were included in the study. Clinicopathological characteristics and complication data were collected and analyzed retrospectively.

Results: Mucosal injury occurred in three cases (1.0 %) and major bleeding occurred in five cases (1.7 %). The gas-related complications were very common; however, only nine cases of major pneumothorax (> 30 % lung collapse) needed therapeutic intervention (3.1 %). Thoracic effusion occurred in 49 patients, 11 of whom had low grade fever or segmental atelectasis that required thoracentesis and drainage (3.8 %). Thus, although the overall incidence of complications was 23.4 % (68/290), only 10.0 % of procedures (29/290) required intervention for complications. Based on the statistical analysis, irregular shape, tumor in the deep muscularis propria layer, long procedure time, and air insufflation were risk factors of STER-related major complications.

Conclusion: Although the incidence of STER-related complications was relatively high, most of these complications were minor and did not require therapeutic intervention. STER is a safe technique for the treatment of upper gastrointestinal SMTs.

* These authors contributed equally to this paper.


 
  • References

  • 1 Demetri GD, Benjamin R, Blanke CD et al. NCCN GIST Task Force. NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST) – expansion and update of NCCN clinical practice guidelines. J Natl Compr Canc Netw 2004; 2: 1-26
  • 2 Xu MD, Cai MY, Zhou PH et al. Submucosal tunneling endoscopic resection: a new technique for treating upper GI submucosal tumors originating from the muscularis propria layer (with videos). Gastrointest Endosc 2012; 75: 195-199
  • 3 Sumiyama K, Tajiri H, Gostout CJ. Submucosal endoscopy with mucosal flap safety valve (SEMF) technique: a safe access method into the peritoneal cavity and mediastinum. Minim Invasive Ther Allied Technol 2008; 17: 365-369
  • 4 Wang XY, Xu MD, Yao LQ et al. Submucosal tunneling endoscopic resection for submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a feasibility study (with videos). Surg Endosc 2014; 28: 1971-1977
  • 5 Ponsaing LG, Kiss K, Hansen MB. Classification of submucosal tumors in the gastrointestinal tract. World J Gastroenterol 2007; 13: 3311-3315
  • 6 Otani Y, Furukawa T, Yoshida M et al. Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumors of the stomach based on analysis of 60 operated cases. Surgery 2006; 139: 484-492
  • 7 Ye LP, Zhang Y, Mao XL et al. Submucosal tunneling endoscopic resection for small upper gastrointestinal subepithelial tumors originating from the muscularis propria layer. Surg Endosc 2014; 28: 524-530
  • 8 Feng Y, Yu L, Yang S et al. Endolumenal endoscopic full-thickness resection of muscularis propria-originating gastric submucosal tumors. J Laparoendosc Adv Surg Tech A 2014; 24: 171-176
  • 9 Zhou PH, Yao LQ, Qin XY et al. Endoscopic full-thickness resection without laparoscopic assistance for gastric submucosal tumors originated from the muscularis propria. Surg Endosc 2011; 25: 2926-2931
  • 10 Ren Z, Zhong Y, Zhou P et al. Perioperative management and treatment for complications during and after peroral endoscopic myotomy (POEM) for esophageal achalasia (EA) (data from 119 cases). Surg Endosc 2012; 26: 3267-3272
  • 11 Maeda Y, Hirasawa D, Fujita N et al. A pilot study to assess mediastinal emphysema after esophageal endoscopic submucosal dissection with carbon dioxide insufflation. Endoscopy 2012; 44: 565-571
  • 12 Maeda Y, Hirasawa D, Fujita N et al. A prospective, randomized, double-blind, controlled trial on the efficacy of carbon dioxide insufflation in gastric endoscopic submucosal dissection. Endoscopy 2013; 45: 335-341
  • 13 Petrin G, Ruol A, Battaglia G et al. Anastomotic stenoses occurring after circular stapling in esophageal cancer surgery. Surg Endosc 2000; 14: 670-674
  • 14 Wang C, Lu X, Chen P. Clinical value of preventive balloon dilatation for esophageal stricture. Exp Ther Med 2013; 5: 292-294
  • 15 Isomoto H, Yamaguchi N, Nakayama T et al. Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol 2011; 11: 46